NS1738 | CAS#501684-93-1 |α7 Positive Modulator

NS1738
featured

WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 532365

CAS#: 501684-93-1

Description: NS1738 is a α7 positive allosteric modulator.

Chemical Structure

NS1738

CAS# 501684-93-1

Product data Instruction

Theoretical Analysis

MedKoo Cat#: 532365
Name: NS1738
CAS#: 501684-93-1
Chemical Formula: C14H9Cl2F3N2O2
Exact Mass: 364.00
Molecular Weight: 365.133
Elemental Analysis: C, 46.05; H, 2.48; Cl, 19.42; F, 15.61; N, 7.67; O, 8.76

Price and Availability

Size	Price	Availability	Quantity
5mg	USD 240
10mg	USD 360
Bulk inquiry Welcome, Customer: Please do not inquire quote if your intended use is for a patient since our products are for research use and for chemical synthesis use, not for human use . For in-stock products, we listed price in the web page. You may inquire prices for which sizes were not listed. If no price is listed, this means the product is not in stock at the moment, which may be available via custom synthesis. For cost-effective reason, minimum order of 1g is requested (typically very expensive). The lead time is usually 2-4 months. Quote of less than 1g will not be provided. MedKoo may not offer quote for below reasons: (1) current available synthetic method appears to be extremely expensive which is obviously not affordable to most customers; (2) Key raw material to make the product is temporally not available; (3) DEA controlled substances; (4) the product is under patent protection in customer’s country.

Synonym: NS1738; NS 1738; NS-1738.

IUPAC/Chemical Name: 3-(5-chloro-2-hydroxyphenyl)-1-[2-chloro-5-(trifluoromethyl)phenyl]urea

InChi Key: OUDXRNQPVSMGDW-UHFFFAOYSA-N

InChi Code: InChI=1S/C14H9Cl2F3N2O2/c15-8-2-4-12(22)11(6-8)21-13(23)20-10-5-7(14(17,18)19)1-3-9(10)16/h1-6,22H,(H2,20,21,23)

SMILES Code: O=C(NC1=CC(Cl)=CC=C1O)NC2=CC(C(F)(F)F)=CC=C2Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:

Product Data

Instruction:

View handling instruction

Biological target:	NS 1738 (NSC 213859) is a novel positive allosteric modulator of the α7 nAChR.
In vitro activity:	This strategy revealed that the extracellular N-terminal domain of alpha7 plays a critical role in allosteric modulation by NS-1738. In addition, alpha7-5HT(3) chimeras harboring the M2-M3 segment showed that spontaneous activity in response to NS-1738, which confirmed the critical contribution of this small extracellular segment in the receptor gating. In contrast to NS-1738, positive allosteric modulation by PNU-120596 could not be restored in the alpha7-5HT(3) chimeras but was selectively observed in the reverse 5HT(3)-alpha7 chimera. Reference: Mol Pharmacol. 2008 Nov;74(5):1407-16. https://pubmed.ncbi.nlm.nih.gov/18678621/
In vivo activity:	NS1738 was modestly brain-penetrant, and it was demonstrated to counteract a (-)-scopolamine-induced deficit in acquisition of a water-maze learning task in rats. Moreover, NS1738 improved performance in the rat social recognition test to the same extent as (-)-nicotine, demonstrating that NS1738 is capable of producing cognitive enhancement in vivo. Reference: J Pharmacol Exp Ther. 2007 Oct;323(1):294-307. https://pubmed.ncbi.nlm.nih.gov/17625074/

Solubility Data

	Solvent	Max Conc. mg/mL	Max Conc. mM
Solubility
	DMF	25.0	68.47
	DMSO	58.6	160.56
	DMSO:PBS (pH 7.2) (1:3)	0.3	0.68
	Ethanol	39.8	109.10

Preparing Stock Solutions

The following data is based on the product molecular weight 365.13 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:	1. Bertrand D, Bertrand S, Cassar S, Gubbins E, Li J, Gopalakrishnan M. Positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor: ligand interactions with distinct binding sites and evidence for a prominent role of the M2-M3 segment. Mol Pharmacol. 2008 Nov;74(5):1407-16. doi: 10.1124/mol.107.042820. Epub 2008 Aug 4. PMID: 18678621. 2. Timmermann DB, Grønlien JH, Kohlhaas KL, Nielsen EØ, Dam E, Jørgensen TD, Ahring PK, Peters D, Holst D, Christensen JK, Malysz J, Briggs CA, Gopalakrishnan M, Olsen GM. An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo. J Pharmacol Exp Ther. 2007 Oct;323(1):294-307. doi: 10.1124/jpet.107.120436. Epub 2007 Jul 11. Erratum in: J Pharmacol Exp Ther. 2009 Dec;331(3):1146. Chrsitensen, Jeppe K [corrected to Christensen, Jeppe K]. PMID: 17625074. 3. 1. Freitas K, Carroll FI, Damaj MI. The antinociceptive effects of nicotinic receptors α7-positive allosteric modulators in murine acute and tonic pain models. J Pharmacol Exp Ther. 2013 Jan;344(1):264-75. doi: 10.1124/jpet.112.197871. Epub 2012 Oct 31. PMID: 23115222; PMCID: PMC3533419.
In vitro protocol:	1. Bertrand D, Bertrand S, Cassar S, Gubbins E, Li J, Gopalakrishnan M. Positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor: ligand interactions with distinct binding sites and evidence for a prominent role of the M2-M3 segment. Mol Pharmacol. 2008 Nov;74(5):1407-16. doi: 10.1124/mol.107.042820. Epub 2008 Aug 4. PMID: 18678621. 2. Timmermann DB, Grønlien JH, Kohlhaas KL, Nielsen EØ, Dam E, Jørgensen TD, Ahring PK, Peters D, Holst D, Christensen JK, Malysz J, Briggs CA, Gopalakrishnan M, Olsen GM. An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo. J Pharmacol Exp Ther. 2007 Oct;323(1):294-307. doi: 10.1124/jpet.107.120436. Epub 2007 Jul 11. Erratum in: J Pharmacol Exp Ther. 2009 Dec;331(3):1146. Chrsitensen, Jeppe K [corrected to Christensen, Jeppe K]. PMID: 17625074.
In vivo protocol:	1. Freitas K, Carroll FI, Damaj MI. The antinociceptive effects of nicotinic receptors α7-positive allosteric modulators in murine acute and tonic pain models. J Pharmacol Exp Ther. 2013 Jan;344(1):264-75. doi: 10.1124/jpet.112.197871. Epub 2012 Oct 31. PMID: 23115222; PMCID: PMC3533419. 2. Timmermann DB, Grønlien JH, Kohlhaas KL, Nielsen EØ, Dam E, Jørgensen TD, Ahring PK, Peters D, Holst D, Christensen JK, Malysz J, Briggs CA, Gopalakrishnan M, Olsen GM. An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo. J Pharmacol Exp Ther. 2007 Oct;323(1):294-307. doi: 10.1124/jpet.107.120436. Epub 2007 Jul 11. Erratum in: J Pharmacol Exp Ther. 2009 Dec;331(3):1146. Chrsitensen, Jeppe K [corrected to Christensen, Jeppe K]. PMID: 17625074.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

Mass

Concentration

Volume

M. Wt* g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Concentration 1

Volume 1

Concentration 2

Volume 2

1: Cheng Q, Yakel JL. Presynaptic α7 nicotinic acetylcholine receptors enhance hippocampal mossy fiber glutamatergic transmission via PKA activation. J Neurosci. 2014 Jan 1;34(1):124-33. doi: 10.1523/JNEUROSCI.2973-13.2014. PubMed PMID: 24381273; PubMed Central PMCID: PMC3866480.

2: Freitas K, Ghosh S, Ivy Carroll F, Lichtman AH, Imad Damaj M. Effects of α7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models. Neuropharmacology. 2013 Feb;65:156-64. doi: 10.1016/j.neuropharm.2012.08.022. Epub 2012 Oct 16. PubMed PMID: 23079470; PubMed Central PMCID: PMC3521074.

Your view history

NS1738 featured